Osve Pharmaceutical

Osve Pharmaceutical is a prominent Iranian pharmaceutical manufacturer headquartered in Tehran, specializing in the development and production of a wide range of medicinal products. Established in 1966 as a joint venture with Pfizer, the company has evolved into a major player in the Middle Eastern healthcare market, focusing on complex generics and biosimilars. Its extensive portfolio covers critical therapeutic areas such as neurology, cardiology, nephrology, and oncology. Osve is particularly recognized for its production of high-tech medications, including glatiramer acetate for multiple sclerosis and sevelamer for chronic kidney disease. The company operates state-of-the-art manufacturing facilities that comply with international GMP standards and is publicly listed on the Tehran Stock Exchange. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), it plays a vital role in the regional pharmaceutical supply chain.